Costs and benefits of cervical screening IV: valuation by women of the cervical screening programme
- 1 December 2001
- journal article
- research article
- Published by Wiley in Cytopathology
- Vol. 12 (6) , 367-376
Abstract
Costs and benefits of cervical screening IV: valuation by women of the cervical screening programme Objectives: To assess the value of the cervical smear test to women, taking account of the positive and negative aspects of the cervical screening service. Design: A postal survey. Setting: Tayside Health Board region of Scotland. Participants: A sample of 2000 women aged 20–59. Main outcome measures: Maximum willingness to pay (WTP) for a cervical smear test. Results: Women were prepared to pay £50.20 per smear on a 3‐yearly basis. Willingness to pay was positively related to income, but unrelated to age and whether or not the respondent had previously had a smear. Conclusions: Previous studies have estimated the cost per screen or cost per life year saved by cervical screening. This study used the economic instrument of WTP to take account of other potential (dis)benefits to women. The value women place on having a smear was more than the cost to the National Health Service (NHS) of providing the service. The output of a WTP study is potentially useful at the policy level. Future work should explore both the value of alternative approaches to cervical screening, and the value of competing health care interventions.Keywords
This publication has 18 references indexed in Scilit:
- Testing for consistency in willingness to pay experimentsJournal of Economic Psychology, 2000
- The Discrete-choice Willingness-to-pay Question Format in Health Economics:Medical Decision Making, 2000
- Valuing the benefits of publicly-provided health care: does ‘ability to pay’ preclude the use of ‘willingness to pay’?Social Science & Medicine, 1999
- Strategic overbidding in contingent valuation: Stated economic value of public goods varies according to consumers expectations of funding sourceJournal of Economic Psychology, 1998
- Costs and benefits of cervical screening. II. Is it worthwhile reducing the screening interval from 5 to 3 years?Cytopathology, 1996
- Willingness to pay for antenatal carrier screening for cystic fibrosisHealth Economics, 1995
- Psychological costs of screening.BMJ, 1989
- Value of a negative cervical smearBMJ, 1988
- The cost of saving a life through cervical cytology screening: implications for health policyHealth Policy, 1987
- An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model.Journal of Epidemiology and Community Health, 1986